Protocol for risk stratification of ischemic events and...

Details Protocol for risk stratification of ischemic events and... Protocol for risk stratification of ischemic events and...

2011-01-21

2011-12-13

Wallenhorst, Maureen (Department: 1777)

Chemistry: analytical and immunological testing

Clotting or clotting factor level tests

C436S063000, C422S073000, C435S013000, C600S369000, C073S064410

Reexamination Certificate

active

08076144

ABSTRACT:
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.

REFERENCES:
patent: 6225126 (2001-05-01), Cohen et al.
patent: 6315995 (2001-11-01), Pinsky et al.
patent: 6537819 (2003-03-01), Cohen et al.
patent: 6613573 (2003-09-01), Cohen
patent: 6787363 (2004-09-01), Cohen et al.
patent: 6797519 (2004-09-01), Cohen et al.
patent: 7179652 (2007-02-01), Cohen et al.
patent: 7192726 (2007-03-01), Carr et al.
patent: 7381536 (2008-06-01), Gurbel
patent: 7732213 (2010-06-01), Cohen et al.
patent: 7754489 (2010-07-01), Cohen

Affiliated with

Also associated with

Rating

Protocol for risk stratification of ischemic events and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protocol for risk stratification of ischemic events and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protocol for risk stratification of ischemic events and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4297654